Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

Scanwell aims to launch at-home 15-minute coronavirus test, but it still needs FDA approval

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

VEnvirotech transforms organic waste into bioplastics

After a year of testing out environmental technologies for a private company, co-founder Patricia Ayma developed a process for bioplastic production using bacteria. The system turns organic matter, such as food waste, into a product that can be used as a biodegradable alternative to single-use plastics. “I realized that it was a simple technology for […]

Luna is a new kind of space company helping biotech find its footing in microgravity

Toronto-based startup Luna Design and Innovation is a prime example of the kind of space company that is increasingly starting up to take advantage of the changing economics of the larger industry. Founded by Andrea Yip, who is also Luna’s CEO, the bootstrapped venture is looking to blaze a trail for biotechnology companies who stand […]

Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990

With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time. The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing his own pet’s struggle with debilitating […]

UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon

Cambridge, UK-based biotech startup Mogrify, which is working on systematizing the development of novel cell therapies in areas such as regenerative medicine, has closed an initial $16 million Series A. The raise from investors Ahren Innovation Capital, Parkwalk and 24Haymarket follows a $4M seed in February — taking its total raised to date to $20M. Put simply, Mogrify’s approach […]

Boston gets a new biotech accelerator with the launch of Petri

As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of new technologies. Backed by the Boston-based venture capital firm Pillar, Petri has a three-year $15 million commitment to back companies […]

Terramera raises $45 million for its technology to reduce the use of chemicals in agriculture

Terramera, a Canadian company selling bio-pesticides and seed treatments to reduce the use of chemicals in agriculture, has raised $45 million in its latest round of financing. The round was led by strategic investor Ospraie Ag Science and the company’s previous backer, Seed2Growth Ventures. Led by Carl Casale, a former Monsanto executive, Ospraie Ag Science […]